The final analysis of a phase I/II study of nivolumab, ipilimumab combined with nintedanib in advanced non-small cell lung cancer

被引：0
作者：
Puri, Sonam
Tanvetyanon, Tawee
Creelan, Ben C.
Shafique, Michael Rahman
Saltos, Andreas Nicholas
Chiappori, Alberto
Haura, Eric B.
Thapa, Ram
Chen, Dung-Tsa
Boyle, Theresa A.
Antonia, Scott Joseph
Gray, Jhanelle Elaine
机构：
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Duke Canc Inst, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9102
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [22] Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
    Reuss, Joshua E.
    Anagnostou, Valsamo
    Cottrell, Tricia R.
    Smith, Kellie N.
    Verde, Franco
    Zahurak, Marianna
    Lanis, Mara
    Murray, Joseph C.
    Chan, Hok Yee
    McCarthy, Caroline
    Wang, Daphne
    White, James R.
    Yang, Stephen
    Battafarano, Richard
    Broderick, Stephen
    Bush, Errol
    Brock, Malcolm
    Ha, Jinny
    Jones, David
    Merghoub, Taha
    Taube, Janis
    Velculescu, Victor E.
    Rosner, Gary
    Illei, Peter
    Pardoll, Drew M.
    Topalian, Suzanne
    Naidoo, Jarushka
    Levy, Ben
    Hellmann, Matthew
    Brahmer, Julie R.
    Chaft, Jamie E.
    Forde, Patrick M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [23] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Lian Jiang
    Dao-yuan Wang
    Zhi-hua Zhu
    Liang-fa Tang
    Xin-heng Hou
    Hong-da Zhao
    Zheng Xie
    Dan-feng Wang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 449 - 453
  • [24] Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
    Jiang, Lian
    Wang, Dao-yuan
    Zhu, Zhi-hua
    Tang, Liang-fa
    Hou, Xin-heng
    Zhao, Hong-da
    Xie, Zheng
    Wang, Dan-feng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 449 - 453
  • [25] Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer: Final results
    Yoshimura, N.
    Kudoh, S.
    Kimura, T.
    Mitsuoka, S.
    Yana, T.
    Hirata, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
    Nishio, Makoto
    Hida, Toyoaki
    Atagi, Shinji
    Sakai, Hiroshi
    Nakagawa, Kazuhiko
    Takahashi, Toshiaki
    Nogami, Naoyuki
    Saka, Hideo
    Takenoyama, Mitsuhiro
    Maemondo, Makoto
    Ohe, Yuichiro
    Nokihara, Hiroshi
    Hirashima, Tomonori
    Tanaka, Hiroshi
    Fujita, Shiro
    Takeda, Koji
    Goto, Koichi
    Satouchi, Miyako
    Isobe, Hiroshi
    Minato, Koichi
    Sumiyoshi, Naoki
    Tamura, Tomohide
    ESMO OPEN, 2017, 2
  • [27] Phase I study of inhaled doxorubicin combined with docetaxel and cisplatin for advanced non-small cell lung cancer
    Kosuri, K
    Otterson, G
    Villalona-Calero, M
    Murren, J
    Gerber, M
    Ellerton, J
    LUNG CANCER, 2005, 49 : S391 - S391
  • [28] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [29] Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study
    Okuma, Y.
    Kitano, S.
    Watanabe, K.
    Yomota, M.
    Hosomi, Y.
    Zenke, Y.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non-Small Cell Lung Cancer
    Otterson, Gregory A.
    Villalona-Calero, Miguel A.
    Hicks, William
    Pan, Xueliang
    Ellerton, John A.
    Gettinger, Scott N.
    Murren, John R.
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2466 - 2473
12345